- Home
- TSHA vs CMP Comparison
TSHA vs CMP Comparison
Compare TSHA & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSHA | CMP |
|---|---|---|
| Founded | 2019 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | TSHA | CMP |
|---|---|---|
| Price | $4.60 | $23.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $11.11 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 2.8M | 549.0K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.56 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $9,773,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,228.40 | $1.77 |
| P/E Ratio | ★ N/A | $53.35 |
| Revenue Growth | ★ 17.28 | N/A |
| 52 Week Low | $1.13 | $9.44 |
| 52 Week High | $6.02 | $27.00 |
Technical Indicators
Market Signals| Indicator | TSHA | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 54.35 |
| Support Level | $4.33 | $17.11 |
| Resistance Level | $4.72 | $25.80 |
| Average True Range (ATR) | 0.28 | 1.00 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 70.00 | 73.23 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.